Abstract
Phase 1 is intended to build alignment between stakeholders, enforce country ownership of the prioritization and sequencing process, adapt the framework to country context, and result in a clear path forward for assessing vaccine candidates.
A virtual meeting should be facilitated by the NITAG Chair, with technical assistance provided as relevant. Key agenda items for this session include:
- Overview of methodology and workplan
- Review of the comprehensive criteria list
- Description of the process to collect feedback for key decision points, including:
- Vaccines to be considered
- Timeframe to be considered
- Criteriato be used to compare vaccines
- Presentation
